Loading...
Please wait, while we are loading the content...
Similar Documents
NVP-BKM120 inhibits colon cancer growth via FoxO3a-dependent PUMA induction
| Content Provider | Semantic Scholar |
|---|---|
| Author | Yang, Shida Li, Xin Guan, Wenchang Qian, Mingqin Yao, Zhicheng Yin, Xiaoxue Zhao, Hongmei |
| Copyright Year | 2017 |
| Abstract | NVP-BKM120, a potent and highly selective PI3K inhibitor, is currently being investigated in phase I/II clinical trials. The mechanisms of action of NVP-BKM120 in colon cancer cells are unclear. In the present study, we investigated how NVP-BKM120 suppresses colon cancer cells growth and potentiates effects of other chemotherapeutic drugs. We found that NVP-BKM120 treatment enhance PUMA induction irrespective of p53 status through the FoxO3a pathway following AKT inhibition. Furthermore, PUMA is required for NVP-BKM120-induced apoptosis in colon cancer cells. In addition, NVP-BKM120 also synergized with 5-Fluorouracil or regorafenib to induce marked apoptosis via PUMA induction. Deficiency of PUMA suppressed apoptosis and antitumor effect of NVP-BKM120 in xenograft model. These results demonstrate a key role of PUMA in mediating the anticancer effects of NVP-BKM120 and suggest that PUMA could be used as an indicator of NVP-BKM120 sensitivity, and also have important implications for it clinical applications. |
| Starting Page | 83052 |
| Ending Page | 83062 |
| Page Count | 11 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://www.oncotarget.com/index.php?journal=oncotarget&op=download&page=article&path%5B%5D=20943&path%5B%5D=66694 |
| PubMed reference number | 29137323v1 |
| Alternate Webpage(s) | https://doi.org/10.18632/oncotarget.20943 |
| DOI | 10.18632/oncotarget.20943 |
| Journal | Oncotarget |
| Volume Number | 8 |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | 1-Phosphatidylinositol 3-Kinase Apoptosis BKM120 Bcl-2-Binding Component 3 Colon Carcinoma FOXO3A protein, human Fluorouracil NVP ABE171 NVP ADW742 Nevirapine Proto-Oncogene Proteins c-akt cancer cell cell growth pan-PIM Kinase Inhibitor NVP-LGB-321 regorafenib |
| Content Type | Text |
| Resource Type | Article |